Cargando…
SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
Somatic mutations or deletions of TP53 and PTEN in ductal carcinoma in situ (DCIS) lesions have been implicated in progression to invasive ductal carcinomas. A recent molecular and mutational analysis of breast cancers revealed that inactivation of tumor suppressors, p53 and PTEN are strongly associ...
Autores principales: | Kim, Gwangil, Ouzounova, Maria, Quraishi, Ahmed A., Davis, April, Tawakkol, Nader, Clouthier, Shawn G., Malik, Fayaz, Paulson, Amanda K., D’Angelo, Rosemarie C., Korkaya, Sumeyye, Baker, Trenton L., Esen, Elif S., Prat, Aleix, Liu, Suling, Kleer, Celina G., Thomas, Dafydd G., Wicha, Max S., Korkaya, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285772/ https://www.ncbi.nlm.nih.gov/pubmed/24531711 http://dx.doi.org/10.1038/onc.2014.4 |
Ejemplares similares
-
Lin28 and HER2: Two stem cell regulators conspire to drive aggressive breast cancer
por: Malik, Fayaz, et al.
Publicado: (2012) -
Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
por: Korkaya, Hasan, et al.
Publicado: (2009) -
Trastuzumab resistance induces EMT to transform HER2(+) PTEN(−) to a triple negative breast cancer that requires unique treatment options
por: Burnett, Joseph P., et al.
Publicado: (2015) -
Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development
por: Lee, Eunmi, et al.
Publicado: (2019) -
Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer
por: Sun, Lichao, et al.
Publicado: (2016)